Search Results - "Valice, Emily"

Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system by Chervo, Tyler C, Elkin, Eric P, Nugent, Joshua R, Valice, Emily, Amsden, Laura B, Ergas, Isaac J, Munneke, Julie R, Flores, Monica, Saelee, Gina N, Hsiao, Crystal A, Schapiro, Jeffery M, Quesenberry, Charles P, Corley, Douglas A, Habel, Laurel A, Kushi, Lawrence H, Skarbinski, Jacek

“…Understanding the relative contributions of SARS-CoV-2 infection-induced and vaccine-induced seroprevalence is key to measuring overall population-level…”
Get full text

The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies by Rivera, Donna R., Henk, Henry J., Garrett‐Mayer, Elizabeth, Christian, Jennifer B., Belli, Andrew J., Bruinooge, Suanna S., Espirito, Janet L., Sweetnam, Connor, Izano, Monika A., Natanzon, Yanina, Robert, Nicholas J., Walker, Mark S., Cohen, Aaron B., Boyd, Marley, Enewold, Lindsey, Hansen, Eric, Honnold, Rebecca, Kushi, Lawrence, Mishra Kalyani, Pallavi S., Pe Benito, Ruth, Sakoda, Lori C., Sharon, Elad, Tymejczyk, Olga, Valice, Emily, Wagner, Joseph, Lasiter, Laura, Allen, Jeff D.

“…The purpose of this study was to evaluate the potential collective opportunities and challenges of transforming real‐world data (RWD) to real‐world evidence…”
Get full text

Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study by Skarbinski, Jacek, Wood, Mariah S., Chervo, Tyler C., Schapiro, Jeffrey M., Elkin, Eric P., Valice, Emily, Amsden, Laura B., Hsiao, Crystal, Quesenberry, Charles, Corley, Douglas A., Kushi, Lawrence H.

“…The incidence of and risk factors for severe clinical outcomes with the Omicron (B.1.1.529) SARS-CoV-2 variant have not been well-defined. We conducted a…”
Get full text

Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019 by Bhimani, Jenna, O'Connell, Kelli, Ergas, Isaac J, Foley, Marilyn, Gallagher, Grace B, Griggs, Jennifer J, Heon, Narre, Kolevska, Tatjana, Kotsurovskyy, Yuriy, Kroenke, Candyce H, Laurent, Cecile A, Liu, Raymond, Nakata, Kanichi G, Persaud, Sonia, Rivera, Donna R, Roh, Janise M, Tabatabai, Sara, Valice, Emily, Bowles, Erin J A, Bandera, Elisa V, Kushi, Lawrence H, Kantor, Elizabeth D

“…Little is known about how use of chemotherapy has evolved in breast cancer patients. We therefore describe chemotherapy patterns for women with stage I-IIIA…”
Get full text

Relative Contribution of Schistosomiasis and Malaria to Anemia in Western Kenya by Valice, Emily M, Wiegand, Ryan E, Mwinzi, Pauline N M, Karanja, Diana M S, Williamson, John M, Ochola, Elizabeth, Samuels, Aaron, Verani, Jennifer R, Leon, Juan S, Secor, W Evan, Montgomery, Susan P

“…Because anemia is one of the markers of morbidity associated with schistosomiasis, it has been proposed as a potential measure to evaluate the impact of…”
Get full text

UACA locus is associated with breast cancer chemoresistance and survival by Zhu, Qianqian, Schultz, Emily, Long, Jirong, Roh, Janise M., Valice, Emily, Laurent, Cecile A., Radimer, Kelly H., Yan, Li, Ergas, Isaac J., Davis, Warren, Ranatunga, Dilrini, Gandhi, Shipra, Kwan, Marilyn L., Bao, Ping-Ping, Zheng, Wei, Shu, Xiao-Ou, Ambrosone, Christine, Yao, Song, Kushi, Lawrence H.

“…Few germline genetic variants have been robustly linked with breast cancer outcomes. We conducted trans-ethnic meta genome-wide association study (GWAS) of…”
Get full text

Impact of Racial/Ethnic Discrimination on Quality of Life Among Breast Cancer Survivors: The Pathways Study by Shariff-Marco, Salma, Sangaramoorthy, Meera, Ellis, Libby, Thomsen, Catherine, Roh, Janise M, Kroenke, Candyce, Valice, Emily, Kwan, Marilyn L, Ambrosone, Christine, Kushi, Lawrence, Scarlett Lin Gomez

“…Although racial/ethnic disparities in health-care access, treatment, and cancer outcomes are well documented, the impact of racial/ethnic discrimination on…”
Get full text

Impact of Racial/Ethnic Discrimination on Quality of Life Among Breast Cancer Survivors by Shariff-Marco, Salma, Sangaramoorthy, Meera, Ellis, Libby, Thomsen, Catherine, Roh, Janise M, Kroenke, Candyce, Valice, Emily, Kwan, Marilyn L, Ambrosone, Christine, Kushi, Lawrence, Gomez, Scarlett Lin

“…Abstract Although racial/ethnic disparities in health-care access, treatment, and cancer outcomes are well documented, the impact of racial/ethnic…”
Get full text

Electronic Family History Screening Tool for Detection of Inherited Cancer Risk: A Prospective Pilot Study by Le, Amy, Valice, Emily, Kobelka, Christine, Janes, Kristen, Hoodfar, Elizabeth, Powell, C. Bethan

“…Family history screening to identify individuals at increased risk for hereditary cancers could be a powerful strategy to prevent cancer but is used…”
Get full text

Patient characteristics associated with primary prophylactic granulocyte colony-stimulating factor (G-CSF) use among women treated for early-stage breast cancer by Gallagher, Grace B, O'Connell, Kelli, Bhimani, Jenna, Blinder, Victoria Susana, Burganowski, Rachael P, Griggs, Jennifer J., Kolevska, Tatjana, Kroenke, Candyce, Laurent, Cecile, Liu, Raymond, Nakata, Kanichi G, Persaud, Sonia, Rivera, Donna, Roh, Janise M., Valice, Emily, Wang, Peng, Bandera, Elisa Victoria, Bowles, Erin Aiello, Kushi, Lawrence H., Kantor, Elizabeth

“…e12605 Background: The National Comprehensive Cancer Network (NCCN) recommends several chemotherapy regimens for early-stage breast cancer that have elevated…”
Get full text

Patient factors associated with chemotherapy modifications: Results from the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study by Kantor, Elizabeth, Bhimani, Jenna, Gallagher, Grace B, Blinder, Victoria Susana, Burganowski, Rachael P, Griggs, Jennifer J., Kolevska, Tatjana, Kroenke, Candyce, Laurent, Cecile, Liu, Raymond, Nakata, Kanichi G, O'Connell, Kelli, Persaud, Sonia, Rivera, Donna, Roh, Janise M., Valice, Emily, Wang, Peng, Bandera, Elisa Victoria, Bowles, Erin Aiello, Kushi, Lawrence H.

“…520 Background: Understanding patient factors associated with an increased likelihood of receiving chemotherapy modifications is important for treatment…”
Get full text

Association between Neighborhood Stressors and Allostatic Load in Breast Cancer Survivors: The Pathways Study by Sangaramoorthy, Meera, Samayoa, Cathy, Inamdar, Pushkar P, Roh, Janise M, Valice, Emily, Hong, Chi-Chen, Kwan, Marilyn L, Ambrosone, Christine B, Kushi, Lawrence H, Gomez, Scarlett Lin, Shariff-Marco, Salma

“…Allostatic load (AL) is an intermediary outcome through which neighborhood drivers of health may impact cancer survivorship outcomes. We examined associations…”
Get full text

Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system by Kantor, Elizabeth D., O’Connell, Kelli, Ergas, Isaac J., Valice, Emily, Roh, Janise M., Bhimani, Jenna, Heon, Narre, Griggs, Jennifer J., Lee, Jean, Bowles, Erin JA, Rivera, Donna R., Kolevska, Tatjana, Bandera, Elisa V, Kushi, Lawrence H

“…Purpose Most cytotoxic drugs are dosed using body surface area (BSA), yet not all cancer patients receive the full BSA-determined dose. Prior work suggests…”
Get full text

The evolving landscape of chemotherapy for the treatment of early-stage breast cancer from 2006-2019: Results of a retrospective cohort study by Bhimani, Jenna, O'Connell, Kelli, Burganowski, Rachael P, Ergas, Isaac J., Gallagher, Grace B, Griggs, Jennifer J., Heon, Narre, Kolevska, Tatjana, Kroenke, Candyce, Laurent, Cecile, Nakata, Kanichi G, Persaud, Sonia, Rivera, Donna R, Roh, Janise M., Tabatabai, Sara, Valice, Emily, Bowles, Erin, Bandera, Elisa, Kushi, Lawrence H., Kantor, Elizabeth

“…6600 Background: Chemotherapy has been a part of the evolving landscape of treatment for women with early-stage breast cancer (EBC). Over the last 20 years,…”
Get full text

Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study by Kwan, Marilyn L., Valice, Emily, Ergas, Isaac J., Roh, Janise M., Caan, Bette J., Cespedes Feliciano, Elizabeth M., Kolevska, Tatjana, Hartman, Terryl J., Quesenberry, Charles P., Ambrosone, Christine B., Kushi, Lawrence H.

“…ABSTRACT Background The impact of alcohol consumption on breast cancer (BC) prognosis remains unclear. Methods The authors examined short‐term alcohol intake…”
Get full text

Evaluation of Algorithms Using Automated Health Plan Data to Identify Breast Cancer Recurrences by Aiello Bowles, Erin J, Kroenke, Candyce H, Chubak, Jessica, Bhimani, Jenna, O'Connell, Kelli, Brandzel, Susan, Valice, Emily, Doud, Rachael, Theis, Mary Kay, Roh, Janise M, Heon, Narre, Persaud, Sonia, Griggs, Jennifer J, Bandera, Elisa V, Kushi, Lawrence H, Kantor, Elizabeth D

“…We updated algorithms to identify breast cancer recurrences from administrative data, extending previously developed methods. In this validation study, we…”
Get full text

Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–IIIA breast cancer by Bhimani, Jenna, O'Connell, Kelli, Persaud, Sonia, Blinder, Victoria, Burganowski, Rachael, Ergas, Isaac J., Foley, Marilyn J., Gallagher, Grace B., Griggs, Jennifer J., Heon, Narre, Kolevska, Tatjana, Kotsurovskyy, Yuriy, Kroenke, Candyce H., Laurent, Cecile A., Liu, Raymond, Nakata, Kanichi G., Rivera, Donna R., Roh, Janise M., Tabatabai, Sara, Valice, Emily, Bandera, Elisa V., Bowles, Erin J. Aiello, Kushi, Lawrence H., Kantor, Elizabeth D.

“…For patients with breast cancer, delays in chemotherapy initiation have been adversely associated with recurrence and survival. We evaluated patient‐level…”
Get full text

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer by Bhimani, Jenna, O’Connell, Kelli, Persaud, Sonia, Blinder, Victoria, Burganowski-Doud, Rachael P., Ergas, Isaac J., Gallagher, Grace B., Griggs, Jennifer J., Heon, Narre, Kolevska, Tatjana, Kotsurovskyy, Yuriy, Kroenke, Candyce H., Laurent, Cecile. A., Liu, Raymond, Nakata, Kanichi G., Rivera, Donna R., Roh, Janise M., Tabatabai, Sara, Valice, Emily, Bandera, Elisa V., Aiello Bowles, Erin J., Kushi, Lawrence H., Kantor, Elizabeth D.

“…Abstract Background: Guidelines informing chemotherapy regimen selection are based on clinical trials with participants who do not necessarily represent…”
Get full text

The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system by Bhimani, Jenna, O’Connell, Kelli, Persaud, Sonia, Blinder, Victoria, Burganowski, Rachael P., Ergas, Isaac J., Gallagher, Grace B., Griggs, Jennifer J., Heon, Narre, Kolevska, Tatjana, Kotsurovskyy, Yuriy, Kroenke, Candyce H., Laurent, Cecile. A., Liu, Raymond, Nakata, Kanichi G., Rivera, Donna R., Roh, Janise M., Tabatabai, Sara, Valice, Emily, Bandera, Elisa V., Aiello Bowles, Erin J., Kushi, Lawrence H., Kantor, Elizabeth D.

“…Purpose The National Comprehensive Cancer Network (NCCN) guidelines recommend a variety of drug combinations with specific administration schedules for the…”
Get full text

An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer by Stewart, Mark, Norden, Andrew D, Dreyer, Nancy, Henk, Henry Joe, Abernethy, Amy P, Chrischilles, Elizabeth, Kushi, Lawrence, Mansfield, Aaron S, Khozin, Sean, Sharon, Elad, Arunajadai, Srikesh, Carnahan, Ryan, Christian, Jennifer B, Miksad, Rebecca A, Sakoda, Lori C, Torres, Aracelis Z, Valice, Emily, Allen, Jeff

“…This pilot study examined the ability to operationalize the collection of real-world data to explore the potential use of real-world end points extracted from…”
Get more information